PASI-100 is associated with better dermatology-specific patient reported outcomes compared with PASI-75–99: Subanalysis of a phase II psoriasis trial of adalimumab

• Book ID: 116582879
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 59 KB
• Volume: 56
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2006.10.846